Our analysis was adjusted for potentially important factors associated with risk for pancreatic cancer, such as smoking, obesity, and history of pancreatitis before GLP-1RA or basal insulin treatment. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.